KB
Kevin Balthaser
DELAYED 1 MONTH
Chief Financial Officer
Aclaris Therapeutics, Inc.
Filings
1
Companies
1
Latest
Mar 1, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Aclaris Therapeutics, Inc.
Kevin Balthaser
Chief Financial Officer
Option Exercise
—
2,375 sh
Mar 3 9:10 PM
Mar 1, 2026